ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 5 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in ProQR Therapeutics N.V. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- 0 vs. Q1 2024
- Shares held
- 17.3M
- −92.5K (−0.5%) vs. Q1 2024
- Total value
- $28.6M
- −$11.1M (−28.0%) vs. Q1 2024
- New holders
- 3
- 5 more added
- Sold out
- 3
- 17 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Privium Fund Management B.V. | 5,580,725 | $9.21M | 2.35% | +236,279+4.4% | Added |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $6.02M | 0.01% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,042,771 | $3.39M | 0.10% | −841,586−29.2% | Reduced |
| M28 Capital Management LP | 1,019,498 | $1.69M | 2.19% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 905,582 | $1.50M | 0.36% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 900,000 | $1.49M | 0.52% | +900,000 | New |
| Macquarie Group Ltd | 620,000 | $1.03M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 483,583 | $802.7K | 0.25% | 00.0% | Unchanged |
| Deutsche Bank AG | 385,149 | $639.3K | 0.00% | 00.0% | Unchanged |
| Monaco Asset Management SAM | 312,629 | $519.0K | 0.26% | 00.0% | Unchanged |
| Franklin Street Advisors Inc | 150,000 | $249.0K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 148,357 | $246.3K | 0.00% | −180,632−54.9% | Reduced |
| Two Sigma Advisers, LP | 131,500 | $218.3K | 0.00% | −30,500−18.8% | Reduced |
| Boothbay Fund Management, LLC | 106,703 | $177.1K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 96,118 | $159.6K | 0.00% | −44,033−31.4% | Reduced |
| Squarepoint Ops LLC | 84,733 | $140.7K | 0.00% | −67,769−44.4% | Reduced |
| Morgan Stanley | 77,942 | $129.4K | 0.00% | +10,351+15.3% | Added |
| Bank of America Corp | 73,163 | $121.5K | 0.00% | −36,944−33.6% | Reduced |
| Two Sigma Investments, LP | 68,945 | $114.4K | 0.00% | −9,999−12.7% | Reduced |
| Schonfeld Strategic Advisors LLC | 61,900 | $102.8K | 0.00% | +61,900 | New |
| BNP Paribas Arbitrage, SA | 51,501 | $85.5K | 0.00% | +16,500+47.1% | Added |
| Geode Capital Management, LLC | 46,671 | $77.5K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 42,000 | $69.7K | 0.00% | −3,000−6.7% | Reduced |
| Bank of Montreal | 30,000 | $53.4K | 0.00% | 00.0% | Unchanged |
| RFG Advisory, LLC | 32,000 | $53.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 27,546 | $45.7K | 0.00% | +22,576+454.2% | Added |
| JustInvest LLC | 21,429 | $35.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,365 | $30.5K | 0.00% | −27,643−60.1% | Reduced |
| Mariner, LLC | 18,334 | $30.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,932 | $26.4K | 0.00% | −1,488−8.5% | Reduced |
| Atom Investors LP | 13,107 | $21.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,471 | $20.7K | 0.00% | −11,262−47.5% | Reduced |
| Advisor Group Holdings, Inc. | 12,250 | $20.3K | 0.00% | −561−4.4% | Reduced |
| EP Wealth Advisors, LLC | 11,500 | $19.1K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,996 | $18.3K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 6,628 | $11.0K | 0.00% | −6,922−51.1% | Reduced |
| Group One Trading, L.P. | 4,090 | $6.79K | 0.00% | −5,600−57.8% | Reduced |
| BlackRock Inc. | 3,945 | $6.55K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 3,933 | $6.00K | 0.00% | −20,830−84.1% | Reduced |
| Royal Bank of Canada | 1,055 | $2.00K | 0.00% | +855+427.5% | Added |
| PFS Partners, LLC | 1,000 | $1.66K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 821 | $1.36K | 0.00% | +821 | New |
| JPMorgan Chase & Co | 314 | $521 | 0.00% | −1,179−79.0% | Reduced |
| Qube Research & Technologies Ltd | 33 | $55 | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 276 | $0 | 0.00% | −3,871−93.3% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,943−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −12,053−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |